By clicking "Allow All" you agree to the storing of cookies on your device to enhance site navigation,
analyse site usage and support us in providing free open access scientific content.
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina launches its first product enabling long- and short-read sequencing on one instrument
Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer
NextSeq 550™ System
NextSeq™ 1000 and NextSeq™ 2000 Systems
NextSeq™ 550Dx sequencer
NovaSeq™ 6000 Sequencing System
NovaSeq™ 6000Dx sequencing instrument
NovaSeq™ X and NovaSeq™ X Plus Sequencing Systems
Ask the experts: Tips and best practices for DNA methylation studies
Cost-effective and high-throughput NGS boosts prospects for widespread personalized medicine
Discover single-cell sequencing workflows
Empower transcriptomics with RNA sequencing
Expert panel discussion – accelerating precision medicine with low-cost whole-genome sequencing
Illumina: 25 years of innovation
Infographic - publication highlights for spatial analysis
Multiomics: An overview of useful methods and applications
Proteomics and transcriptomics with universal NGS readout
What is metatranscriptomics?